| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.097 | 0.002 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.092 | 0.004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.006 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.087 | 0.008 |